Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.69NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.98NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.71NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.90NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.18.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.26.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LQ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MB.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
unclassifiableNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KS.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCENSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.9.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.37 (Lambda)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.14 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used